Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Putnam

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The AAPS Journal|August 8, 2008
Use of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibodyWendy S Putnam, Jing Li, Jonas Haggstrom, et al.
Respiratory Medicine|February 8, 2018
Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroidsPhilip Korenblat, Edwin Kerwin, Igor Leshchenko, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 18, 2013
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challengeH Scheerens, J R Arron, Y Zheng, et al.
Journal of Clinical Pharmacology|December 29, 2021
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe AsthmaNaoki Kotani, Michael Dolton, Robin J Svensson, et al.
Mabs|June 20, 2013
Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodiesDeborah L Mortensen, Saileta Prabhu, Eric G Stefanich, et al.
Ecology and Evolution|September 21, 2016
Genetic connectivity across marginal habitats: the elephants of the Namib DesertYasuko Ishida, Peter J Van Coeverden de Groot, Keith E A Leggett, et al.
Pulmonary Pharmacology & Therapeutics|September 30, 2021
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polypsRui Zhu, Ryan Owen, Justin Wilkins, et al.
British Journal of Cancer|July 2, 2014
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancerS J Cohen, A A Konski, S Putnam, et al.
Clinical and Translational Allergy|July 18, 2022
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)Stanley J Szefler, Graham Roberts, Adalberto S Rubin, et al.
Msystems|October 16, 2025
Bladder health and the urogenital microbiome in community-dwelling adult femalesL Brubaker, D McDonald, S Putnam, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The AAPS Journal|August 8, 2008
Use of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibodyWendy S Putnam, Jing Li, Jonas Haggstrom, et al.
Respiratory Medicine|February 8, 2018
Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroidsPhilip Korenblat, Edwin Kerwin, Igor Leshchenko, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 18, 2013
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challengeH Scheerens, J R Arron, Y Zheng, et al.
Journal of Clinical Pharmacology|December 29, 2021
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe AsthmaNaoki Kotani, Michael Dolton, Robin J Svensson, et al.
Mabs|June 20, 2013
Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodiesDeborah L Mortensen, Saileta Prabhu, Eric G Stefanich, et al.
Ecology and Evolution|September 21, 2016
Genetic connectivity across marginal habitats: the elephants of the Namib DesertYasuko Ishida, Peter J Van Coeverden de Groot, Keith E A Leggett, et al.
Pulmonary Pharmacology & Therapeutics|September 30, 2021
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polypsRui Zhu, Ryan Owen, Justin Wilkins, et al.
British Journal of Cancer|July 2, 2014
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancerS J Cohen, A A Konski, S Putnam, et al.
Clinical and Translational Allergy|July 18, 2022
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)Stanley J Szefler, Graham Roberts, Adalberto S Rubin, et al.
Msystems|October 16, 2025
Bladder health and the urogenital microbiome in community-dwelling adult femalesL Brubaker, D McDonald, S Putnam, et al.
Pageof 10